15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Telix Pharmaceuticals Limited, 4 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $20.00 to $22.00, so the covering firms are broadly aligned. The average target of $21.00 sits 106% above the current $10.18. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Telix Pharmaceuticals Limited.
As of Jul, 4 of 5 firms rate TLX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
Top analysts covering Telix Pharmaceuticals Limited
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TLX.
#1
David Nierengarten
Wedbush · Rank #115
Buy
$22.00+116.1% to target
Overall win rate
41%
+ Follow
#2
RB
Robert Burns
HC Wainwright & Co. · Rank #195
Buy
$20.00+96.5% to target
Overall win rate
38%
+ Follow
#3
LS
Laura Sutcliffe
Citigroup
Buy
$22.00+116.1% to target
Coverage
—
+ Follow
#4
LS
Laura Sutcliffe
UBS
Buy
$22.00+116.1% to target
Coverage
—
+ Follow
#5
DD
David Dai
UBS
Buy
$20.00+96.5% to target
Coverage
—
+ Follow
TLX stock forecast FAQ
What is TLX's average 12-month price target?+
The 4 analysts with a live target average $21.00 for Telix Pharmaceuticals Limited over the next 12 months, ranging from a $22.00 high to a $20.00 low.
Is TLX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TLX?+
The Street-high target is $22.00 (Citigroup), and the Street-low is $20.00 (HC Wainwright & Co.). The average of all 4 active targets is $21.00.
How many Wall Street analysts cover TLX?+
5 analysts have an active rating on Telix Pharmaceuticals Limited, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering TLX?+
Among analysts who currently cover TLX, David Nierengarten of Wedbush has the strongest overall Quantellect track record (Rank #115). Their current call is Buy with a $22.00 target.
Have analysts been upgrading or downgrading TLX lately?+
As of Jul, 4 of 5 firms rate TLX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TLX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
